" class="no-js "lang="en-US"> Central Nervous System Archives - Medtech Alert
Tuesday, February 07, 2023

Sort by:

Date

Top Post

Coave Therapeutics Strengthens Leadership Team with the Appointments of Catherine Mathis as Vice President Regulatory Affairs and Julien Berger as Head of Legal Affairs

Coave Therapeutics (‘Coave’), a clinical-stage biotechnology company focused on developing life-changing gene therapies for CNS […]

eCential Robotics Receives FDA Clearance for Its Surgical Robotic Platform for Spine Surgery

eCential Robotics, a French growth MedTech company that designs and produces a system unifying 2D/3D […]

IVX Health Announces Opening of New Infusion Centers in Connecticut

IVX Health, a national provider of infusion and injection therapy for adult and pediatric patients with multiple […]

Applications for Proposed First-of-a-kind Multiple Sclerosis Biosimilar Natalizumab Accepted by US FDA and EMA

Sandoz, a global leader in generic and biosimilar medicines, announced today that the US Food […]

Coave Therapeutics Announces Formation of Scientific Advisory Board to Drive its Pipeline Strategy for Next-generation Gene Therapies Targeting CNS Diseases

Coave Therapeutics (‘Coave’), a clinical-stage biotechnology company focused on developing life-changing gene therapies for CNS […]

Computer Tool Can Track Stroke Rehabilitation to Boost Recovery

A sensor-equipped computer program can accurately identify and count arm movements in people undergoing stroke […]

Vironix Health has Partnered with The Landon Pediatric Foundation to Bring AI-Healthcare Technology to Southern California

Digital Health Company Vironix Health has teamed up with LPF to increase access to affordable healthcare and […]

ABL and Coave Therapeutics Collaborate to Develop Manufacturing Processes and Create Joint Capabilities for Process Development

Coave Therapeutics (‘Coave’), a clinical-stage biotechnology company focused on developing life-changing gene therapies for CNS […]

NRG Therapeutics Announces £2.68m Innovate UK Award to Develop New Medicines to Treat Parkinson's and Motor Neuron Disease

NRG Therapeutics Ltd (“NRG” or “company”), an innovative neuroscience company targeting mitochondrial dysfunction, is pleased […]

  1. Halozyme Appoints Barbara Duncan to its Board of Directors Read more
  2. Dianosic Raises €4.7M to Bring Treatment for Chronic Rhinitis into Clinical Trial Read more
  3. Clexio and Genetika+ Announce Partnership Using Proprietary Antidepressant Screening Platform Read more
  4. Mihir Patel Joins Cambia Health Solutions as Chief Pharmacy Officer Read more
  5. Sandoz Biologics License Application for Proposed Biosimilar Denosumab Accepted by US FDA Read more